Download FREE Report Sample
Download Free sampleRabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
Human Rabies Vaccine Market contains market size and forecasts of Human Rabies Vaccine in global, including the following market information:
Global Human Rabies Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Rabies Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Rabies Vaccine companies in 2021 (%)
The global Human Rabies Vaccine market was valued at 1086.6 million in 2021 and is projected to reach US$ 1441 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vero Cell Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Rabies Vaccine include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological and ZhongKe Biopharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Rabies Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Rabies Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Vaccine Market Segment Percentages, by Type, 2021 (%)
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Global Human Rabies Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Vaccine Market Segment Percentages, by Application, 2021 (%)
Pre-Exposure Vaccine
Post-Exposure Vaccine
Global Human Rabies Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Rabies Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Rabies Vaccine revenues share in global market, 2021 (%)
Key companies Human Rabies Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Rabies Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
